Connect
MJA
MJA

Rethinking psychotropics in nursing homes

Sarah N Hilmer and Danijela Gnjidic
Med J Aust 2013; 198 (2): . || doi: 10.5694/mja12.11593
Published online: 4 February 2013

While evidence supports psychotropic use in nursing homes in some scenarios, we use them too often, for too long, at doses too high and in dangerous combinations with other medications

The potentially inappropriate use of psychotropic medications (antipsychotics, hypnotics, anxiolytics and antidepressants) in residential aged care facilities (RACFs) is of considerable community concern. It is of practical and ethical importance to assess the use of these medications and the feasibility of reducing their use, and to devise alternative strategies to improve the care of vulnerable people living in RACFs.


  • 1 Royal North Shore Hospital and University of Sydney, Sydney, NSW.
  • 2 Faculty of Pharmacy and Centre for Education and Research on Ageing, University of Sydney, Sydney, NSW.


Correspondence: sarah.hilmer@sydney.edu.au

Competing interests:

No relevant disclosures.

  • 1. Snowdon J, Galanos D, Vaswani D. Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. Int Psychogeriatr 2011 Mar 24: 1-6.
  • 2. Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011; 59: 875-880.
  • 3. Deudon A, Maubourguet N, Gervais X, et al. Non-pharmacological management of behavioural symptoms in nursing homes. Int J Geriatr Psychiatry 2009; 24: 1386-1395.
  • 4. Ballard CG, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer’s disease. Cochrane Database Syst Rev 2006; (1): CD003476.
  • 5. Ruths S, Straand J, Nygaard HA, et al. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004; 52: 1737-1743.
  • 6. Bains J, Birks J, Dening T. Antidepressants for depression in dementia. Cochrane Database Syst Rev 2002; (4): CD003944.
  • 7. Huybrechts KF, Rothman KJ, Silliman RA, et al. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ 2011; 183: E411-E419.
  • 8. Hilmer SN, Gnjidic D, Le Couteur DG. Thinking through the medication list. Appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician 2012; 41: 924-928.
  • 9. Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16: 621-632.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.